Product NDC: | 55111-557 |
Proprietary Name: | Fexofenadine HCl and Pseudoephedrine HCI |
Non Proprietary Name: | Fexofenadine HCl and Pseudoephedrine HCI |
Active Ingredient(s): | 180; 240 mg/1; mg/1 & nbsp; Fexofenadine HCl and Pseudoephedrine HCI |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55111-557 |
Labeler Name: | Dr.Reddy's Laboratories Limited |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | ANDA079043 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110824 |
Package NDC: | 55111-557-07 |
Package Description: | 1 BLISTER PACK in 1 CARTON (55111-557-07) > 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
NDC Code | 55111-557-07 |
Proprietary Name | Fexofenadine HCl and Pseudoephedrine HCI |
Package Description | 1 BLISTER PACK in 1 CARTON (55111-557-07) > 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK |
Product NDC | 55111-557 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Fexofenadine HCl and Pseudoephedrine HCI |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20110824 |
Marketing Category Name | ANDA |
Labeler Name | Dr.Reddy's Laboratories Limited |
Substance Name | FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE |
Strength Number | 180; 240 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes |